Table 1 Baseline demographic characteristics of each cohort
N =251/group | Â | Group A (RA) | Group B (DM) | Group C (GP) | P; All three | P; A versus C |
|---|---|---|---|---|---|---|
Age | Years (SD) | 48.5 (10.0) | 49.1 (9.8) | 49.0 (9.3) | 0.8 | Â |
Gender | Male | 47 (19%) | 47 (19%) | 47 (19%) | 1 | Â |
| Â | Female | 204 (81%) | 204 (81%) | 204 (81%) | Â | Â |
Race | Caucasian | 203 (81%) | 203 (81%) | 203 (81%) | Â | Â |
| Â | African-American | 27 (11%) | 27 (11%) | 27 (11%) | Â | Â |
| Â | Asian | 17 (7%) | 17 (7%) | 17 (7%) | Â | Â |
| Â | Other | 4 (< 2%) | 4 (< 2%) | 4 (< 2%) | Â | Â |
Disease duration | Years (SD) | 10.0 (8.4) | 9.3 (9.0) | N/A | 0.08 | N/A |
Personal history | HTN | 71 (28%) | 130 (52%) | 71 (28%) | < 0.0001 | 1 |
| Â | HL | 55 (22%) | 114 (45%) | 48 (19%) | < 0.0001 | 0.5 |
| Â | CAD | 5 (2%) | 27 (11%) | 6 (2%) | < 0.0001 | 1 |
| Â | MI | 5 (2%) | 12 (5%) | 2 (1%) | .01 | 0.4 |
| Â | CVA | 4 (2%) | 14 (6%) | 4 (2%) | .009 | 1 |
Family history | CAD | 74 (30%) | 95 (38%) | 62 (25%) | 0.005 | 0.3 |
| Â | MI | 30 (12%) | 49 (20%) | 28 (11%) | 0.012 | 0.9 |
| Â | CVA | 35 (14%) | 25 (10%) | 25 (10%) | 0.3 | 0.2 |
CRP | Â | 0.9 | N/A | N/A | Â | Â |
Hemoglobin A1c | Â | N/A | 7.5 | N/A | Â | Â |